117 related articles for article (PubMed ID: 23697529)
1. Transient sunitinib resistance in gastrointestinal stromal tumors.
Bracci R; Maccaroni E; Cascinu S
N Engl J Med; 2013 May; 368(21):2042-3. PubMed ID: 23697529
[No Abstract] [Full Text] [Related]
2. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
J Cancer Res Ther; 2011; 7(4):491-3. PubMed ID: 22269418
[No Abstract] [Full Text] [Related]
3. [Sunitinib for gastrointestinal stromal cell tumors and advanced renal cell carcinoma].
Vollmer H
Med Monatsschr Pharm; 2006 Oct; 29(10):386-7. PubMed ID: 17058904
[No Abstract] [Full Text] [Related]
4. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
Caram MV; Schuetze SM
J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
[TBL] [Abstract][Full Text] [Related]
5. Long-term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene.
Yang J; Ikezoe T; Nishioka C; Takezaki Y; Hanazaki K; Taguchi T; Yokoyama A
Int J Cancer; 2012 Feb; 130(4):959-66. PubMed ID: 21445973
[TBL] [Abstract][Full Text] [Related]
6. VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib.
Koh Y; Lee HE; Im SA; Kim SH; Kim TM; Han SW; Oh DY; Kim JH; Lee SH; Kim DW; Kim TY; Kim WH; Heo DS; Bang YJ
Diagn Mol Pathol; 2011 Sep; 20(3):143-7. PubMed ID: 21817899
[TBL] [Abstract][Full Text] [Related]
7. [Gastrointestinal stromal tumor (GIST)--tyrosine kinase inhibitors].
Nishida T; Yoshidome K; Tori M
Nihon Rinsho; 2012 Nov; 70 Suppl 8():452-6. PubMed ID: 23513883
[No Abstract] [Full Text] [Related]
8. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
De Giorgi U
Future Oncol; 2013 Nov; 9(11):1675-7. PubMed ID: 23862700
[No Abstract] [Full Text] [Related]
9. [A case of a gastrointestinal stromal tumor of the rectum effectively treated with continuously-administered regorafenib after failure of imatinib and sunitinib].
Kajiura S; Hosokawa A; Nanjyo S; Nakada N; Ando T; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2016 Apr; 113(4):655-61. PubMed ID: 27052395
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.
Kefeli U; Buyuberber S; Akyol M; Yildiz R; Kaplan MA; Ciltas A; Sevinc A; Karaca H; Seker M; Ozdemir N; Alacacioglu A; Coskun U; Isikdogan A; Dane F; Gumus M; Ozkan M; Suner A; Tarhan MO; Benekli M
Hepatogastroenterology; 2013 Jun; 60(124):647-52. PubMed ID: 23165189
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
Shen L
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
[No Abstract] [Full Text] [Related]
12. [Efficacy and safety of sunitinib on patients with imatinib-resistant gastrointestinal stromal tumor].
Liu X; Jiang WZ; Guan GX; Chen ZF; Chi P; Lu HS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):221-5. PubMed ID: 23536339
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy.
Banzo I; Quirce R; Martinez-Rodriguez I; Jimenez-Bonilla J; Sainz-Esteban A; Barragan J; Portilla-Quattrociocchi H; Carril JM
Clin Nucl Med; 2008 Mar; 33(3):211-2. PubMed ID: 18287850
[No Abstract] [Full Text] [Related]
14. Jejunal Gastrointestinal Stromal Tumor.
Yousef AJA
Mayo Clin Proc; 2017 Oct; 92(10):1602. PubMed ID: 28982490
[No Abstract] [Full Text] [Related]
15. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.
Ruka W; Rutkowski P; Szawłowski A; Nowecki Z; Debiec-Rychter M; Grzesiakowska U; Dziewirski W; Siedlecki JA; Michej W
Eur J Surg Oncol; 2009 Jan; 35(1):87-91. PubMed ID: 18289826
[TBL] [Abstract][Full Text] [Related]
16. The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects.
Seandel M; Shia J; Linkov I; Maki RG; Antonescu CR; Dupont J
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6203-4. PubMed ID: 17062698
[No Abstract] [Full Text] [Related]
17. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
18. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
Lee NR; Yhim HY; Yim CY; Kwak JY; Song EK
Ann Pharmacother; 2011 Oct; 45(10):e56. PubMed ID: 21954449
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib and Thrombosis.
Lamba G; Deol R; Shah D; Sahni R; Malhotra BK
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S128-30. PubMed ID: 21881834
[No Abstract] [Full Text] [Related]
[Next] [New Search]